Drug intelligence / Profile preview

Collagenase for Injection

Development stage
Unknown
Lead developer
Grand Life Sciences
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Injection
01

Overview

Collagenase for Injection is an enzymatic debriding agent developed and marketed by Grand Life Sciences (Liaoning) Co., Ltd., a subsidiary of Grand Life Sciences Group. Approved in China as a National Class 1 new drug, it is a biologic enzyme designed for wound management and debridement. The drug functions by selectively degrading collagen, a major structural component of the extracellular matrix, within necrotic or devitalized tissue. By breaking down these collagen fibers, the enzyme facilitates the removal of debris from wounds, such as chronic ulcers or burns, without damaging healthy tissue, thereby promoting the natural healing process. While collagenase is frequently used in topical ointment forms, this specific product is formulated as an injection for targeted enzymatic debridement.

Brand names
Collagenase for Injection
Other names
CollagenaseCollagenase Grand Life Sciences

Beyond the preview

Go deeper on Collagenase for Injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagenase for Injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call